- Investing Ideas
- /
- Telecom Healthcare Sector
Telecom Healthcare Sector
Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
Tvardi Therapeutics
Market Cap: US$250.7m
Operates as a biotechnology company that develops medicines for cancer, chronic inflammation diseases, and fibrosis diseases.
TVRD
US$25.23
7D
-1.5%
1Y
n/a
Alpha Tau Medical
Market Cap: US$250.6m
A clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.
DRTS
US$2.79
7D
-5.4%
1Y
-1.4%
Lifecore Biomedical
Market Cap: US$248.4m
Operates as an integrated contract development and manufacturing organization in the United States.
LFCR
US$6.90
7D
-1.1%
1Y
17.5%
Cerus
Market Cap: US$246.6m
Operates as a biomedical products company.
CERS
US$1.33
7D
3.1%
1Y
-32.5%
Corvus Pharmaceuticals
Market Cap: US$246.0m
A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.
CRVS
US$3.61
7D
-18.5%
1Y
57.6%
Tristel
Market Cap: UK£183.7m
Develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.
TSTL
UK£3.85
7D
-2.5%
1Y
-12.5%
ZimVie
Market Cap: US$242.6m
Develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide.
ZIMV
US$9.01
7D
2.9%
1Y
-47.1%
Phathom Pharmaceuticals
Market Cap: US$242.4m
A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.
PHAT
US$4.09
7D
30.1%
1Y
-61.2%
Monopar Therapeutics
Market Cap: US$241.8m
A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.
MNPR
US$37.16
7D
-5.7%
1Y
1,118.4%
Foghorn Therapeutics
Market Cap: US$240.2m
A clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States.
FHTX
US$4.43
7D
5.5%
1Y
-19.6%
Allogene Therapeutics
Market Cap: US$238.4m
A clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases.
ALLO
US$1.11
7D
-4.3%
1Y
-59.9%
Palvella Therapeutics
Market Cap: US$238.1m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.
PVLA
US$22.05
7D
-3.2%
1Y
n/a
Monte Rosa Therapeutics
Market Cap: US$238.0m
A clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins.
GLUE
US$3.98
7D
-2.7%
1Y
-23.5%
Creative Medical Technology Holdings
Market Cap: US$237.0m
A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.
CELZ
US$2.02
7D
-5.6%
1Y
-54.6%
Aquestive Therapeutics
Market Cap: US$236.4m
Operates as a pharmaceutical company in the United States and internationally.
AQST
US$2.38
7D
-14.7%
1Y
-23.5%
Gossamer Bio
Market Cap: US$236.3m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.
GOSS
US$1.04
7D
-6.3%
1Y
49.9%
ProKidney
Market Cap: US$236.1m
A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.
PROK
US$0.81
7D
11.8%
1Y
-80.1%
Atea Pharmaceuticals
Market Cap: US$234.5m
A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.
AVIR
US$2.74
7D
0.7%
1Y
-24.9%
MaxCyte
Market Cap: UK£175.4m
A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.
MXCT
UK£1.65
7D
-8.3%
1Y
-56.0%
Jade Biosciences
Market Cap: US$232.5m
Operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.
JBIO
US$7.35
7D
-15.1%
1Y
n/a
Third Harmonic Bio
Market Cap: US$232.4m
A biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases.
THRD
US$5.18
7D
0.6%
1Y
-62.6%
Vanda Pharmaceuticals
Market Cap: US$231.6m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$4.16
7D
5.3%
1Y
-24.1%
Omeros
Market Cap: US$231.4m
A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.
OMER
US$3.22
7D
-48.0%
1Y
-6.8%
Oncology Institute
Market Cap: US$230.3m
An oncology company, provides various medical oncology services in the United States.
TOI
US$2.99
7D
6.8%
1Y
367.9%
Cipher Pharmaceuticals
Market Cap: CA$319.9m
Operates as a specialty pharmaceutical company in Canada.
CPH
CA$12.48
7D
-10.3%
1Y
43.6%
Bright Minds Biosciences
Market Cap: CA$318.6m
A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.
DRUG
CA$45.23
7D
-0.02%
1Y
3,062.9%
Optima Health
Market Cap: UK£170.9m
Provides occupational health and wellbeing services for the public and private sectors in the United Kingdom.
OPT
UK£1.93
7D
-1.3%
1Y
n/a
Astria Therapeutics
Market Cap: US$225.2m
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.
ATXS
US$3.96
7D
-6.4%
1Y
-58.5%
Animalcare Group
Market Cap: UK£169.0m
Develops, sells, and distributes licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets in Europe and internationally.
ANCR
UK£2.45
7D
0.8%
1Y
7.0%
Tactile Systems Technology
Market Cap: US$224.3m
A medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.
TCMD
US$10.40
7D
9.0%
1Y
-24.3%
Nuvectis Pharma
Market Cap: US$219.3m
A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.
NVCT
US$9.87
7D
9.8%
1Y
60.5%
Acelyrin
Market Cap: US$219.1m
A clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
SLRN
US$2.25
7D
-4.7%
1Y
-48.7%
Amarin
Market Cap: US$217.8m
A pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.
AMRN
US$10.58
7D
1.6%
1Y
-39.2%
MediWound
Market Cap: US$216.0m
A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.
MDWD
US$20.48
7D
16.9%
1Y
20.6%
Dimerix
Market Cap: AU$335.9m
A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.
DXB
AU$0.59
7D
-9.8%
1Y
58.7%
Rezolute
Market Cap: US$215.5m
A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.
RZLT
US$3.57
7D
-3.5%
1Y
35.2%